Perioperative Single-Donor Platelet Apheresis and Red Blood Cell Transfusion Impact on 90-Day and Overall Survival in Living Donor Liver Transplantation

Background: Although many previous studies have confirmed that perioperative blood transfusion is associated with poor outcomes after liver transplantation (LT), few studies described the influence of single-donor platelet apheresis transfusion in living donor LT (LDLT). This study aimed to assess the effect of blood products on outcomes for LDLT recipients, focusing on apheresis platelets. Methods: This retrospective study included 126 recipients who underwent their first adult-to-adult LDLT. Twenty-four variables including consumption of blood products of 126 LDLT recipients were assessed for their link to short-term outcomes and overall survival. Kaplan-Meier survival curve and the log-rank test were used for recipient survival analysis. A multivariate Cox proportional-hazard model and a propensity score analysis were applied to adjust confounders after potential risk factors were identified by a univariate Cox analysis. Results: Patients who received apheresis platelet transfusion had a lower 90-day cumulative survival (78.9% vs. 94.2%, P = 0.009), but had no significant difference in overall survival in the Cox model, compared with those without apheresis platelet transfusion. Units of apheresis platelet transfusion (hazard ratio [HR] = 3.103, 95% confidence interval [CI]: 1.720–5.600, P < 0.001) and preoperative platelet count (HR = 0.170, 95% CI: 0.040–0.730, P = 0.017) impacted 90-day survival independently. Multivariate Cox regression analysis also found that units of red blood cell (RBC) transfusion (HR = 1.036, 95% CI: 1.006–1.067, P = 0.018), recipient's age (HR = 1.045, 95% CI: 1.005–1.086, P = 0.025), and ABO blood group comparison (HR = 2.990, 95% CI: 1.341–6.669, P = 0.007) were independent risk factors for overall survival after LDLT. Conclusions: This study suggested that apheresis platelets were only associated with early mortality but had no impact on overall survival in LDLT. Units of RBC, recipient's age, and ABO group comparison were independent predictors of long-term outcomes.

[1]  S. Lee,et al.  Association Between Intraoperative Platelet Transfusion and Early Graft Regeneration in Living Donor Liver Transplantation , 2016, Annals of surgery.

[2]  B. Shi,et al.  Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status , 2016, Chinese medical journal.

[3]  J. Chin,et al.  Thrombocytopenia, Platelet Transfusion, and Outcome Following Liver Transplantation , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[4]  G. Song,et al.  A review of current status of living donor liver transplantation. , 2016, Hepatobiliary surgery and nutrition.

[5]  W. Peng,et al.  Postoperative Low Absolute Lymphocyte Counts may Predict Poor Outcomes of Hepatocellular Carcinoma After Liver Resection , 2016, Chinese medical journal.

[6]  D. Sinn,et al.  Case‐matched comparison of ABO‐incompatible and ABO‐compatible living donor liver transplantation , 2016, The British journal of surgery.

[7]  A. Ejaz,et al.  Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative. , 2015, Journal of the American College of Surgeons.

[8]  S. Hendren,et al.  Variation in Transfusion Practices and the Effect on Outcomes After Noncardiac Surgery. , 2015, Annals of surgery.

[9]  A. Leon-Justel,et al.  Point-of-care haemostasis monitoring during liver transplantation reduces transfusion requirements and improves patient outcome. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[10]  Y. Kimura,et al.  Impact of platelets and serotonin on liver regeneration after living donor hepatectomy. , 2015, Transplantation proceedings.

[11]  S. Lee.  A Complete Treatment of Adult Living Donor Liver Transplantation: A Review of Surgical Technique and Current Challenges to Expand Indication of Patients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  S. Mallett,et al.  Transfusion and coagulation management in liver transplantation. , 2014, World journal of gastroenterology.

[13]  Q. Xia,et al.  Operative outcomes of adult living donor liver transplantation and deceased donor liver transplantation: A systematic review and meta‐analysis , 2014, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  W. Chapman,et al.  Perioperative blood transfusion affects hepatitis C virus (HCV)-specific immune responses and outcome following liver transplantation in HCV-infected patients. , 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[15]  W. Xiao,et al.  Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components , 2013, Vox sanguinis.

[16]  J. Cywinski,et al.  Transfusion of older red blood cells is associated with decreased graft survival after orthotopic liver transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  M. Gawaz,et al.  Platelets in tissue repair: control of apoptosis and interactions with regenerative cells. , 2013, Blood.

[18]  Johnny C. Hong,et al.  Blood transfusion requirement during liver transplantation is an important risk factor for mortality. , 2013, Journal of the American College of Surgeons.

[19]  P. Meer.  Platelet concentrates, from whole blood or collected by apheresis? , 2013 .

[20]  S. Gitto,et al.  Influence of Age and Gender Before and After Liver Transplantation , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[21]  T. Wen,et al.   Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. , 2012, Annals of hepatology.

[22]  L. Naldi,et al.  The impact of perioperative transfusion of blood products on survival after pediatric liver transplantation , 2012, Pediatric transplantation.

[23]  R. Thiele,et al.  Duration of red blood cell storage and outcomes following orthotopic liver transplantation , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  Guihua Chen,et al.  Prognostic factors for late mortality after liver transplantation for benign end-stage liver disease. , 2011, Chinese medical journal.

[25]  T. Wen,et al.  Predictors of patient survival following living donor liver transplantation. , 2011, Hepatobiliary & pancreatic diseases international : HBPD INT.

[26]  P. Austin.  An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies , 2011, Multivariate behavioral research.

[27]  B. Seifert,et al.  Impact of preoperative right-ventricular function and platelet transfusion on outcome after lung transplantation. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[28]  S. Biggins,et al.  Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[29]  À. Rovira,et al.  Hepatic encephalopathy is associated with posttransplant cognitive function and brain volume , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[30]  F. Locatelli,et al.  Analysis of survival after primary liver transplantation: multivariate analysis of 155 cases in a single center. , 2010, Transplantation proceedings.

[31]  E. Vamvakas.  COMMENTARY: Relative safety of pooled whole blood–derived versus single‐donor (apheresis) platelets in the United States: a systematic review of disparate risks , 2009, Transfusion.

[32]  R. Porte,et al.  Platelet Transfusion During Liver Transplantation Is Associated with Increased Postoperative Mortality Due to Acute Lung Injury , 2009, Anesthesia and analgesia.

[33]  R. Porte,et al.  Platelets in liver transplantation: Friend or foe? , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[34]  I. Boin,et al.  Intraoperative massive transfusion decreases survival after liver transplantation. , 2008, Transplantation proceedings.

[35]  R. Porte,et al.  The Impact of Intraoperative Transfusion of Platelets and Red Blood Cells on Survival After Liver Transplantation , 2008, Anesthesia and analgesia.

[36]  H. Shimada,et al.  Outcomes of Adult-to-Adult Living Donor Liver Transplantation: A Single Institution's Experience With 335 Consecutive Cases , 2007, Annals of surgery.

[37]  Peter C Austin,et al.  A comparison of propensity score methods: a case‐study estimating the effectiveness of post‐AMI statin use , 2006, Statistics in medicine.

[38]  Z. Katsarava,et al.  Neurological complications after cadaveric and living donor liver transplantation , 2006, Journal of Neurology.

[39]  Sandler Sg.  Platelet transfusions for bleeding during coronary artery bypass graft surgery. , 2005 .

[40]  A. Roy,et al.  Survival rate changes with transfusion of blood products during liver transplantation , 2005, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[41]  S. Todo,et al.  Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma: Experience in Japan , 2004, Annals of surgery.

[42]  E. Jaurrieta,et al.  Intraoperative red blood cell transfusion in liver transplantation: Influence on patient outcome, prediction of requirements, and measures to reduce them , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[43]  G. Song,et al.  LIVING DONOR LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA : FEASIBILITY OF EXPANDED INCLUSION CRITERIA , 2014 .

[44]  H. Chung,et al.  Intraoperative predictors of short-term mortality in living donor liver transplantation due to acute liver failure. , 2013, Transplantation proceedings.

[45]  P. F. van der Meer.  Platelet concentrates, from whole blood or collected by apheresis? , 2013, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[46]  X. Ning.  LIVING DONOR LIVER TRANSPLANTATION FOR ADULT PATIENTS WITH HEPATOCELLULAR CARCINOMA , 2011 .

[47]  B. Müllhaupt,et al.  Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation. , 2008, Journal of hepatology.

[48]  S. Sandler.  Platelet transfusions for bleeding during coronary artery bypass graft surgery. , 2005, Current hematology reports.

[49]  D. Pressey.  Friend or FoE? , 1983, Nature.